National transfusion registries from twenty-two countries
Blood Doesn't Choose
Your blood type is inherited from your parents. In Romania, over a third of people have A positive; AB negative, the rarest, appears in one person in a hundred. Pick your type on the dial to explore basic ABO/RhD compatibility for red-cell transfusions, then compare blood-group frequencies across countries.
What a blood type actually marks
Red-cell surfaces carry antigens, structures made of proteins or carbohydrates. The ABO system distinguishes the A and B antigens: type A has A, type B has B, AB has both, and O has neither of these two antigens. Separately, RhD indicates whether the D antigen is present. This gives the eight ABO/RhD combinations on the dial. Other antigen systems also matter for transfusions.
For red-cell transfusions, O negative is the universal donor within the ABO and RhD systems, and AB positive is the universal recipient. Plasma follows different rules: AB plasma can be given across ABO groups, whereas O plasma contains anti-A and anti-B antibodies. Platelets involve additional considerations. The transfusion service determines compatibility for a patient through blood grouping, antibody screening and the necessary compatibility testing.
The ABO group is inherited by one of the few textbook rules that really hold: one gene, three versions. On the traits that don’t, from earlobes to tongue rolling: Your earlobe doesn’t obey Mendel.
Pick your type
The dial shows only basic ABO/RhD red-cell compatibility. Its eight sectors use red for RhD-positive types and blue for RhD-negative types. Select a group to see who it can donate red cells to, who it can receive red cells from, and its frequency in the Romanian data. Plasma and platelets follow different criteria.
Touch a sector
The corridor of type B
Type B shares differ across countries. In the figures used here, type B accounts for 11% in Ireland, 9% in the Netherlands and 11% in Germany; the figure for Austria is 14%. Values are higher in some Asian countries, but the series does not rise steadily eastward: Czechia and Slovakia are at 18%, Romania at 16%, Moldova at 20.6%, Turkey at 15.3%, Israel at 19%, and India at 34.1%. Romania’s share is about 45% higher than Ireland’s.
What nearly vanishes toward the east
RhD-negative traces an even steeper gradient. In Ireland, nearly one person in six is RhD-negative; in France and Germany, nearly one in seven; in Romania, also one in seven; toward Turkey, one in eight. In India it drops to one in seventeen, and across East Asia it almost disappears: one in two hundred in Japan, one in three hundred thirty in South Korea. In this dataset, RhD-negative accounts for 16% in Ireland and 0.5% in Japan: a ratio of 32 to one. The ratio of about 53 to one applies only to O negative (8% versus 0.15%).
Method and sources
Compatibility
The dial is an educational model of ABO/RhD red-cell compatibility. Type O lacks A and B antigens; its red cells still carry other antigens. Plasma follows different rules, and platelets involve additional requirements. Lifeblood explains component compatibility separately. Pretransfusion testing includes ABO/RhD grouping, antibody screening and compatibility testing. The clinical team selects the component and product for an individual patient.
Compatibility information was checked against transfusion-service sources on 23 October 2026.
Sources
The country percentages come from national transfusion services and local red cross societies — the Irish Blood Transfusion Service, the Japanese Red Cross Society, Sanquin (Netherlands), Blutspendedienst (Germany), Národná transfúzna služba (Slovakia), Magen David Adom (Israel), Donor.ro for Romania, "Nicolae Testemițanu" State University of Medicine for Moldova — supplemented by South Korea's official statistics service (KOSIS) and two peer-reviewed surveys, for India and Jordan. Every set of eight percentages was checked to add up to nearly exactly 100%; where the total drifted noticeably, as for the United Kingdom or Iceland, the country was left out of the numeric comparisons.
The Ireland–Japan comparison adds all four RhD-negative groups. The 2018 IBTS report, p. 24 gives 9% B positive and 2% B negative; IBTS also gives 1% AB negative. The Japanese Red Cross distinguishes 0.5% RhD-negative from 0.15% O-negative.
Limits
The estimates come from donor samples, not from testing entire populations, and the methodology and collection year differ from country to country. Converting percentages into people, for Romania, uses a rounded figure of 19 million residents.